Journal of Nuclear Cardiology

, Volume 21, Issue 3, pp 655–659 | Cite as

Role of multimodality imaging in the early identification of cardiac sarcoidosis

  • Hanna N. AhmedEmail author
  • Yehuda Edo Paz
  • Jason Stuck
  • Mathew Maurer
  • Sabahat Bokhari
Images That Teach
A 40-year-old male presented to the emergency department complaining of palpitations and was found to be in stable monomorphic ventricular tachycardia (Figure 1). He underwent a thorough diagnostic workup. Cardiac catheterization revealed normal coronary arteries and endomyocardial biopsy was nondiagnostic. However, based on findings from multiple imaging modalities including cardiac MRI (Figure 2), transthoracic echocardiography (Figure 3A), and cardiac PET (Figure 4, first and second rows; and Figure 5), a clinical diagnosis of cardiac sarcoidosis was made. High-dose steroids were initiated and he underwent placement of an ICD before discharge. After completing a course of steroids, repeat imaging revealed improved left ventricular function and resolution of regional cardiac inflammation (Figure 3B; and Figure 4, third row). The patient continues to do well clinically with no symptoms or arrhythmias.


Sarcoidosis Cardiac Involvement Multiple Imaging Endomyocardial Biopsy Multimodality Imaging 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Conflict of interest

The authors have indicated that they have no financial conflict of interest.

Supplementary material

Supplementary material 1 (MP4 176 kb)

Supplementary material 1 (M4V 875 kb)


  1. 1.
    Uemura A, Morimoto S, Hiramitsu S, Kato Y, Ito T, Hishida H. Histologic diagnostic rate of cardiac sarcoidosis: Evaluation of endomyocardial biopsies. Am Heart J 1999;138:299-302.PubMedCrossRefGoogle Scholar
  2. 2.
    Youssef G, Leung E, Mylonas I, Nery P, Williams K, Wisenberg G, et al. The use of F-18 FDG PET in the diagnosis of cardiac sarcoidosis: A systematic review and meta-analysis including the Ontario experience. J Nucl Med 2012;53:241-8.PubMedCrossRefGoogle Scholar
  3. 3.
    Ohira H, Tsujino I, Ishimaru S, Oyama N, Takei T, Tsukamoto E, et al. Myocardial imaging with 18F-fluoro-2-deoxyglucose positron emission tomography and magnetic resonance imaging in sarcoidosis. Eur J Nucl Med Mol Imaging 2008;35:933-41.PubMedCrossRefGoogle Scholar

Copyright information

© American Society of Nuclear Cardiology 2014

Authors and Affiliations

  • Hanna N. Ahmed
    • 1
    Email author
  • Yehuda Edo Paz
    • 1
  • Jason Stuck
    • 1
  • Mathew Maurer
    • 1
  • Sabahat Bokhari
    • 1
  1. 1.Division of Cardiology, Department of MedicineColumbia University Medical Center and New York Presbyterian HospitalNew YorkUSA

Personalised recommendations